Ann: Change of Director's Interest Notice * 3, page-77

this is exactly the point. If Pilbars were referring to your `simple truths' then it would be fine. Saying the company hasn't had any successful trials is garbage. Plain and simple. People chest beating about selling doesn't prove anything either. Markets move, share prices move for a host of reasons. Company hasn't done anything wrong in the last 2 years. If you have better opportunities, great. However right now, BOT is very asymmetric in its risk reward. Pilbar and the rubbish about the downside being zero is hilarious. It cannot trade there, I won't let it..haha. Anyway, for those that can't see value, move on. Numerous successful trials, FDA can see it, and the value in S.B is enormous